首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
bronchial asthma exacerbation(moderate) 相关文献:
Classification of asthma.
Padem N, Saltoun C.
Allergy Asthma Proc. 2019 Nov 1;40(6):385-388. doi: 10.2500/aap.2019.40.4253.
PMID:31690376
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].
Chinese Thoracic Society, Chinese Medical Association.
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
PMID:40050074
Vitamin D for the management of asthma.
Williamson A, Martineau AR, Sheikh A, Jolliffe D, Griffiths CJ.
Cochrane Database Syst Rev. 2023 Feb 6;2(2):CD011511. doi: 10.1002/14651858.CD011511.pub3.
PMID:36744416
Asthma.
Lemanske RF Jr, Busse WW.
JAMA. 1997 Dec 10;278(22):1855-73.
PMID:9396647
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.
Nakagome K, Nagata M.
Biomolecules. 2024 May 2;14(5):546. doi: 10.3390/biom14050546.
PMID:38785953
Diagnosis and Treatment Options for T2-Low Asthma.
Thomas D, Hamada Y, Gibson P, Brightling CE, Castro M, Heaney LG.
J Allergy Clin Immunol Pract. 2025 Jul;13(7):1527-1539. doi: 10.1016/j.jaip.2025.04.055. Epub 2025 May 13.
PMID:40373870
Bronchial thermoplasty for severe asthma.
Thomson NC, Bicknell S, Chaudhuri R.
Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):241-8. doi: 10.1097/ACI.0b013e32835335ca.
PMID:22475996
Real-world effectiveness of dupilumab in patients with asthma: Findings from the US ADVANTAGE study.
Blaiss M, Bleecker ER, Jacob-Nara J, Nair R, Duh MS, Wang Z, Stanford RH, Soler X, Hardin M, Ye M, Khanal A, Borsos K.
Ann Allergy Asthma Immunol. 2024 Apr;132(4):463-468.e1. doi: 10.1016/j.anai.2023.11.006. Epub 2023 Nov 14.
PMID:37967668
MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-kappaB pathway.
Liu L, Zhou L, Wang L, Mao Z, Zheng P, Zhang F, Zhang H, Liu H.
Respir Res. 2023 Oct 25;24(1):255. doi: 10.1186/s12931-023-02550-y.
PMID:37880668
Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study.
Bleecker E, Blaiss M, Jacob-Nara J, Huynh L, Duh MS, Guo T, Ye M, Stanford RH, Wang Z, Soler X, Nag A, Nair R, Borsos K.
J Allergy Clin Immunol. 2024 Dec;154(6):1500-1510. doi: 10.1016/j.jaci.2024.07.029. Epub 2024 Aug 24.
PMID:39186985
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3